<List><item><source>MED</source><extId>30023013</extId><pmcid>PMC6029241</pmcid><annotations><annotation><prefix>GD peptide (PDB ID: </prefix><exact>3VI4</exact><postfix>) chlorotoxin (PDB I</postfix><tags><tag><name>3VI4</name><uri>http://identifiers.org/pdb/3VI4</uri></tag></tags><id>http://europepmc.org/articles/PMC6029241#europepmc-04c61b41a09e072e26882690b4d25488</id><type>Accession Numbers</type><section>Figure (http://semanticscience.org/resource/SIO_000080)</section><provider>Europe PMC</provider><subType>PDBe</subType></annotation><annotation><prefix>hlorotoxin (PDB ID: </prefix><exact>1CHL</exact><postfix>) azurin p28 peptide</postfix><tags><tag><name>1CHL</name><uri>http://identifiers.org/pdb/1CHL</uri></tag></tags><id>http://europepmc.org/articles/PMC6029241#europepmc-32929d9b6241a801cfc3bec0605a8e2e</id><type>Accession Numbers</type><section>Figure (http://semanticscience.org/resource/SIO_000080)</section><provider>Europe PMC</provider><subType>PDBe</subType></annotation><annotation><prefix>28 peptide (PDB ID: </prefix><exact>4AZU</exact><postfix>) Nucant (N6L) [52] </postfix><tags><tag><name>4AZU</name><uri>http://identifiers.org/pdb/4AZU</uri></tag></tags><id>http://europepmc.org/articles/PMC6029241#europepmc-31f64e0222146400bc8d2100423e0007</id><type>Accession Numbers</type><section>Figure (http://semanticscience.org/resource/SIO_000080)</section><provider>Europe PMC</provider><subType>PDBe</subType></annotation><annotation><prefix>52] aptamer (PDB ID </prefix><exact>4HQU</exact><postfix>) and antibody (PDB </postfix><tags><tag><name>4HQU</name><uri>http://identifiers.org/pdb/4HQU</uri></tag></tags><id>http://europepmc.org/articles/PMC6029241#europepmc-0906f5618e458f7bc0e593c1d8393c1e</id><type>Accession Numbers</type><section>Figure (http://semanticscience.org/resource/SIO_000080)</section><provider>Europe PMC</provider><subType>PDBe</subType></annotation><annotation><prefix> (PDB ID 4HQU) and antibody (PDB ID: </prefix><exact>1IGT</exact><postfix>). </postfix><tags><tag><name>1IGT</name><uri>http://identifiers.org/pdb/1IGT</uri></tag></tags><id>http://europepmc.org/articles/PMC6029241#europepmc-d3936e43f2ed96a07bc83bcc1cb0bec6</id><type>Accession Numbers</type><section>Figure (http://semanticscience.org/resource/SIO_000080)</section><provider>Europe PMC</provider><subType>PDBe</subType></annotation><annotation><prefix>II clinical trials (</prefix><exact>NCT01711398</exact><postfix>), while the MultiFu</postfix><tags><tag><name>NCT01711398</name><uri>http://identifiers.org/clinicaltrials/NCT01711398</uri></tag></tags><id>http://europepmc.org/articles/PMC6029241#europepmc-f780fdddf31190cf06edceff2fa136f0</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>n cancer diagnosis (</prefix><exact>NCT00003763</exact><postfix>) and therapy (NCT00</postfix><tags><tag><name>NCT00003763</name><uri>http://identifiers.org/clinicaltrials/NCT00003763</uri></tag></tags><id>http://europepmc.org/articles/PMC6029241#europepmc-876ec2e84fa2c6a6f5fe47593ed111e9</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>03763) and therapy (</prefix><exact>NCT00291785</exact><postfix>, NCT00485563, NCT00</postfix><tags><tag><name>NCT00291785</name><uri>http://identifiers.org/clinicaltrials/NCT00291785</uri></tag></tags><id>http://europepmc.org/articles/PMC6029241#europepmc-d15cdff241ba8c7d293b91786873ac0e</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>d therapy (NCT00291785, </prefix><exact>NCT00485563</exact><postfix>, NCT00441870). </postfix><tags><tag><name>NCT00485563</name><uri>http://identifiers.org/clinicaltrials/NCT00485563</uri></tag></tags><id>http://europepmc.org/articles/PMC6029241#europepmc-677a47798615b42b16c196ac022c8fcc</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>d therapy (NCT00291785, NCT00485563, </prefix><exact>NCT00441870</exact><postfix>). </postfix><tags><tag><name>NCT00441870</name><uri>http://identifiers.org/clinicaltrials/NCT00441870</uri></tag></tags><id>http://europepmc.org/articles/PMC6029241#europepmc-15aced10385ba6c11386edfbbf9af08b</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>in clinical trials (</prefix><exact>NCT00051584</exact><postfix>), and the use of li</postfix><tags><tag><name>NCT00051584</name><uri>http://identifiers.org/clinicaltrials/NCT00051584</uri></tag></tags><id>http://europepmc.org/articles/PMC6029241#europepmc-530d894769e9a3e2db8bd0fecd4230e2</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>omal formulations for drug delivery (</prefix><exact>NCT01227941</exact><postfix>). </postfix><tags><tag><name>NCT01227941</name><uri>http://identifiers.org/clinicaltrials/NCT01227941</uri></tag></tags><id>http://europepmc.org/articles/PMC6029241#europepmc-d2d7f0a0bf0e8a94700d304bfd95b033</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>different contexts (</prefix><exact>NCT00972946</exact><postfix>, NCT01169935 and NC</postfix><tags><tag><name>NCT00972946</name><uri>http://identifiers.org/clinicaltrials/NCT00972946</uri></tag></tags><id>http://europepmc.org/articles/PMC6029241#europepmc-714d795708e57260935b57d4bfd46e62</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>ntexts (NCT00972946, </prefix><exact>NCT01169935</exact><postfix> and NCT01127113). </postfix><tags><tag><name>NCT01169935</name><uri>http://identifiers.org/clinicaltrials/NCT01169935</uri></tag></tags><id>http://europepmc.org/articles/PMC6029241#europepmc-e6d10b986738eb784a835d675b7850d0</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>ntexts (NCT00972946, NCT01169935 and </prefix><exact>NCT01127113</exact><postfix>). </postfix><tags><tag><name>NCT01127113</name><uri>http://identifiers.org/clinicaltrials/NCT01127113</uri></tag></tags><id>http://europepmc.org/articles/PMC6029241#europepmc-4f3156f9be7d43259d741bb792dd073d</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation></annotations></item></List>